United States Biotechnology & Medical Research

Cytokinetics Inc (CYTK)

Track

Track

Cytokinetics experienced significant insider selling over the past ninety days, totaling approximately 18.6 million dollars in net value. Executives, including CEO Robert I. Blum, executed multiple divestments. These transactions occurred following the August 2026 results financiers, where the firm reported an earnings beat. No insider purchases were recorded during this period.
Ticker: CYTK Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cytokinetics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Robert I. Blum President, CEO, Director Non-Executive Director
Transaction date
Proposed sale
Price
266.95
Quantity 84,625
Value US$4,102,485
2.7
Landry Robert E Non-Executive Director
Transaction date
Sale
Price
483.97
Quantity 45,114 +9.2%
Value US$568,790
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
431.40
Quantity 58,314 -38.5%
Value US$1,227,029
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Planned sale
Price
73.44
Quantity 1,000 -1.9%
Value US$100,000
2.7
Landry Robert E Non-Executive Director
Transaction date
Sale
Price
74.66
Quantity 1,000 -9.8%
Value US$100,000
2.7
ROBERT LANDRY Director Non-Executive Director
Transaction date
Proposed sale
Price
73.62
Quantity 1,000
Value US$100,000
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
75.46
Quantity 1,000 -2.2%
Value US$100,000
3.8
PARSHALL B LYNNE Non-Executive Director
Transaction date
Sale
Price
71.48
Quantity 1,000 -31.7%
Value US$100,000
3.8
B LYNNE PARSHALL Director Non-Executive Director
Transaction date
Proposed sale
Price
70.91
Quantity 1,000
Value US$100,000
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
70.24
Quantity 1,000 -14.6%
Value US$100,000
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
70.24
Quantity 1,000 -1.9%
Value US$100,000
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
75.82
Quantity 3,500 -2.2%
Value US$265,370
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
76.76
Quantity 7,500 -1.9%
Value US$575,700
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
79.88
Quantity 14,000 -19.3%
Value US$1,118,320
2.9
ANDREW CALLOS Officer Officer
Transaction date
Proposed sale
Price
78.39
Quantity 24,000
Value US$1,881,240
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
80.87
Quantity 7,500 -1.9%
Value US$606,525
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
80.59
Quantity 3,500 -2.2%
Value US$282,065
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
82.02
Quantity 7,490 -1.9%
Value US$614,330
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
82.02
Quantity 10 -0.0%
Value US$820
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
86.62
Quantity 3,500 -2.2%
Value US$303,170
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
86.62
Quantity 3,500 -2.2%
Value US$303,170
3.6
FADY MALIK Officer Officer
Transaction date
Proposed sale
Price
85.57
Quantity 24,500
Value US$2,096,465
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
84.92
Quantity 7,500 -1.9%
Value US$636,900
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
85.80
Quantity 15,000 -20.4%
Value US$1,287,000
3.0
Lee Sung EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
87.79
Quantity 1,112 -1.7%
Value US$97,622
2.7
ROBERT BLUM Director; Officer Executive Director
Transaction date
Proposed sale
Price
85.19
Quantity 52,500
Value US$4,472,475
3.0
Lee Sung EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
85.00
Quantity 3,134 -4.7%
Value US$266,390
3.0
Sung Lee Officer Officer
Transaction date
Proposed sale
Price
82.19
Quantity 9,503
Value US$781,052
3.0
Sung Lee Officer Officer
Transaction date
Proposed sale
Price
80.80
Quantity 6,695
Value US$540,956
3.0
Lee Sung EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
82.30
Quantity 38,730 -38.0%
Value US$3,187,479
3.0
Sung Lee Officer Officer
Transaction date
Proposed sale
Price
80.01
Quantity 38,730
Value US$3,098,787
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
79.51
Quantity 3,500 -2.2%
Value US$278,285
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
70.46
Quantity 7,500 -1.9%
Value US$528,450
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
67.98
Quantity 3,500 -2.2%
Value US$237,930
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Sale
Price
76.09
Quantity 2,933 -22.2%
Value US$223,172
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
74.08
Quantity 15,000 -20.4%
Value US$1,111,200
3.8
PARSHALL B LYNNE Non-Executive Director
Transaction date
Sale
Price
74.08
Quantity 5,000 -24.1%
Value US$370,400
2.8
EDWARD KAYE Director Non-Executive Director
Transaction date
Proposed sale
Price
76.76
Quantity 2,933
Value US$225,137
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
77.21
Quantity 7,500 -1.9%
Value US$579,075
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
75.69
Quantity 3,500 -2.2%
Value US$264,915
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
77.92
Quantity 7,500 -1.8%
Value US$584,400
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
77.37
Quantity 3,500 -2.2%
Value US$270,795
2.9
WENDELL WIERENGA Director Non-Executive Director
Transaction date
Proposed sale
Price
66.05
Quantity 4,032
Value US$266,314
3.7
JOHN HENDERSON Director Non-Executive Director
Transaction date
Proposed sale
Price
66.05
Quantity 20,000
Value US$1,321,000
3.0
SUNG LEE Officer Officer
Transaction date
Proposed sale
Price
66.05
Quantity 23,906
Value US$1,578,991
2.9
WIERENGA WENDELL Non-Executive Director
Transaction date
Sale
Price
75.00
Quantity 4,032 -11.0%
Value US$302,400
3.0
Lee Sung EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
76.87
Quantity 23,906 -27.4%
Value US$1,837,654
3.7
HENDERSON JOHN T Non-Executive Director
Transaction date
Sale
Price
75.97
Quantity 20,000 -21.0%
Value US$1,519,400
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
77.25
Quantity 11,333 -16.2%
Value US$875,474
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
65.00
Quantity 15,857 -21.3%
Value US$1,030,705
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
63.26
Quantity 15,000 -20.4%
Value US$948,900
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
59.62
Quantity 7,500 -1.8%
Value US$447,150
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
65.69
Quantity 3,500 -2.2%
Value US$229,915
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
66.02
Quantity 7,449 -11.3%
Value US$491,783
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
65.38
Quantity 7,500 -1.8%
Value US$490,350
2.9
ANDREW CALLOS Officer Officer
Transaction date
Proposed sale
Price
66.35
Quantity 79,639
Value US$5,284,048
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
64.75
Quantity 1,000 -0.6%
Value US$64,750
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
65.21
Quantity 3,500 -2.2%
Value US$228,235
3.6
FADY MALIK Officer Officer
Transaction date
Proposed sale
Price
64.94
Quantity 22,000
Value US$1,428,680
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
66.63
Quantity 7,500 -1.7%
Value US$499,725
2.7
ROBERT BLUM Director; Officer Executive Director
Transaction date
Proposed sale
Price
65.91
Quantity 45,000
Value US$2,965,950
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
65.00
Quantity 3,639 -5.2%
Value US$236,535
2.9
ANDREW CALLOS Officer Officer
Transaction date
Proposed sale
Price
62.97
Quantity 3,639
Value US$229,148
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
62.07
Quantity 1,930 -2.4%
Value US$119,795
2.9
ANDREW CALLOS Officer Officer
Transaction date
Proposed sale
Price
62.13
Quantity 1,930
Value US$119,911
3.0
Lee Sung EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
62.15
Quantity 4,935 -5.4%
Value US$306,710
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
62.15
Quantity 2,916 -3.9%
Value US$181,229
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
62.15
Quantity 5,626 -7.0%
Value US$349,656
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
62.15
Quantity 4,397 -2.8%
Value US$273,274
3.6
Malik Fady Ibraham EVP Research & Development Officer
Transaction date
Sale
Price
62.15
Quantity 7,636 -4.6%
Value US$474,577
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
62.15
Quantity 23,928 -5.3%
Value US$1,487,125
2.7
Blum Robert I President & CEO Executive Director
Transaction date
Sale
Price
62.15
Quantity 12,673 -2.7%
Value US$787,627
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
61.03
Quantity 1,709 -3.6%
Value US$104,300
2.9
ANDREW CALLOS Officer Officer
Transaction date
Proposed sale
Price
60.06
Quantity 1,709
Value US$102,643
2.9
Callos Andrew EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
60.72
Quantity 2,582 -5.1%
Value US$156,779
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-15 2026-09-15 PrS Proposed sale
2.7
Robert I. Blum

President, CEO, Director

Non-Executive Director
84,625
266.95
US$4,102,485 		84,625 266.95 US$4,102,485
2026-09-15 2026-09-15 S Sale
2.7
Landry Robert E
Non-Executive Director
45,114 +9.2%
483.97
US$568,790 		45,114 +9.2% 483.97 US$568,790
2026-09-15 2026-09-15 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
58,314 -38.5%
431.40
US$1,227,029 		58,314 -38.5% 431.40 US$1,227,029
2026-09-15 2026-09-14 PlS Planned sale
2.7
Blum Robert I

President & CEO

Executive Director
1,000 -1.9%
73.44
US$100,000 		1,000 -1.9% 73.44 US$100,000
2026-09-11 2026-09-11 S Sale
2.7
Landry Robert E
Non-Executive Director
1,000 -9.8%
74.66
US$100,000 		1,000 -9.8% 74.66 US$100,000
2026-09-11 2026-09-11 PrS Proposed sale
2.7
ROBERT LANDRY

Director

Non-Executive Director
1,000
73.62
US$100,000 		1,000 73.62 US$100,000
2026-09-08 2026-09-08 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
1,000 -2.2%
75.46
US$100,000 		1,000 -2.2% 75.46 US$100,000
2026-09-01 2026-09-01 S Sale
3.8
PARSHALL B LYNNE
Non-Executive Director
1,000 -31.7%
71.48
US$100,000 		1,000 -31.7% 71.48 US$100,000
2026-09-01 2026-09-01 PrS Proposed sale
3.8
B LYNNE PARSHALL

Director

Non-Executive Director
1,000
70.91
US$100,000 		1,000 70.91 US$100,000
2026-08-31 2026-08-31 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
1,000 -14.6%
70.24
US$100,000 		1,000 -14.6% 70.24 US$100,000
2026-08-31 2026-08-31 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
1,000 -1.9%
70.24
US$100,000 		1,000 -1.9% 70.24 US$100,000
2026-08-18 2026-08-18 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
3,500 -2.2%
75.82
US$265,370 		3,500 -2.2% 75.82 US$265,370
2026-08-10 2026-08-10 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
7,500 -1.9%
76.76
US$575,700 		7,500 -1.9% 76.76 US$575,700
2026-07-30 2026-07-30 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
14,000 -19.3%
79.88
US$1,118,320 		14,000 -19.3% 79.88 US$1,118,320
2026-07-30 2026-07-30 PrS Proposed sale
2.9
ANDREW CALLOS

Officer

Officer
24,000
78.39
US$1,881,240 		24,000 78.39 US$1,881,240
2026-07-27 2026-07-27 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
7,500 -1.9%
80.87
US$606,525 		7,500 -1.9% 80.87 US$606,525
2026-07-23 2026-07-21 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
3,500 -2.2%
80.59
US$282,065 		3,500 -2.2% 80.59 US$282,065
2026-07-14 2026-07-13 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
7,490 -1.9%
82.02
US$614,330 		7,490 -1.9% 82.02 US$614,330
2026-07-14 2026-07-13 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
10 -0.0%
82.02
US$820 		10 -0.0% 82.02 US$820
2026-07-07 2026-07-07 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
3,500 -2.2%
86.62
US$303,170 		3,500 -2.2% 86.62 US$303,170
2026-07-07 2026-07-07 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
3,500 -2.2%
86.62
US$303,170 		3,500 -2.2% 86.62 US$303,170
2026-07-07 2026-07-07 PrS Proposed sale
3.6
FADY MALIK

Officer

Officer
24,500
85.57
US$2,096,465 		24,500 85.57 US$2,096,465
2026-07-02 2026-07-01 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
7,500 -1.9%
84.92
US$636,900 		7,500 -1.9% 84.92 US$636,900
2026-07-02 2026-07-01 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
15,000 -20.4%
85.80
US$1,287,000 		15,000 -20.4% 85.80 US$1,287,000
2026-07-02 2026-07-01 S Sale
3.0
Lee Sung

EVP, Chief Financial Officer

Officer
1,112 -1.7%
87.79
US$97,622 		1,112 -1.7% 87.79 US$97,622
2026-07-01 2026-07-01 PrS Proposed sale
2.7
ROBERT BLUM

Director; Officer

Executive Director
52,500
85.19
US$4,472,475 		52,500 85.19 US$4,472,475
2026-06-29 2026-06-29 S Sale
3.0
Lee Sung

EVP, Chief Financial Officer

Officer
3,134 -4.7%
85.00
US$266,390 		3,134 -4.7% 85.00 US$266,390
2026-06-29 2026-06-29 PrS Proposed sale
3.0
Sung Lee

Officer

Officer
9,503
82.19
US$781,052 		9,503 82.19 US$781,052
2026-06-26 2026-06-26 PrS Proposed sale
3.0
Sung Lee

Officer

Officer
6,695
80.80
US$540,956 		6,695 80.80 US$540,956
2026-06-29 2026-06-24 S Sale
3.0
Lee Sung

EVP, Chief Financial Officer

Officer
38,730 -38.0%
82.30
US$3,187,479 		38,730 -38.0% 82.30 US$3,187,479
2026-06-24 2026-06-24 PrS Proposed sale
3.0
Sung Lee

Officer

Officer
38,730
80.01
US$3,098,787 		38,730 80.01 US$3,098,787
2026-06-23 2026-06-23 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
3,500 -2.2%
79.51
US$278,285 		3,500 -2.2% 79.51 US$278,285
2026-06-15 2026-06-15 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
7,500 -1.9%
70.46
US$528,450 		7,500 -1.9% 70.46 US$528,450
2026-06-09 2026-06-09 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
3,500 -2.2%
67.98
US$237,930 		3,500 -2.2% 67.98 US$237,930
2026-06-01 2026-06-01 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
2,933 -22.2%
76.09
US$223,172 		2,933 -22.2% 76.09 US$223,172
2026-06-01 2026-06-01 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
15,000 -20.4%
74.08
US$1,111,200 		15,000 -20.4% 74.08 US$1,111,200
2026-06-01 2026-06-01 S Sale
3.8
PARSHALL B LYNNE
Non-Executive Director
5,000 -24.1%
74.08
US$370,400 		5,000 -24.1% 74.08 US$370,400
2026-06-01 2026-06-01 PrS Proposed sale
2.8
EDWARD KAYE

Director

Non-Executive Director
2,933
76.76
US$225,137 		2,933 76.76 US$225,137
2026-05-28 2026-05-27 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
7,500 -1.9%
77.21
US$579,075 		7,500 -1.9% 77.21 US$579,075
2026-05-20 2026-05-19 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
3,500 -2.2%
75.69
US$264,915 		3,500 -2.2% 75.69 US$264,915
2026-05-14 2026-05-14 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
7,500 -1.8%
77.92
US$584,400 		7,500 -1.8% 77.92 US$584,400
2026-05-05 2026-05-05 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
3,500 -2.2%
77.37
US$270,795 		3,500 -2.2% 77.37 US$270,795
2026-05-05 2026-05-05 PrS Proposed sale
2.9
WENDELL WIERENGA

Director

Non-Executive Director
4,032
66.05
US$266,314 		4,032 66.05 US$266,314
2026-05-05 2026-05-05 PrS Proposed sale
3.7
JOHN HENDERSON

Director

Non-Executive Director
20,000
66.05
US$1,321,000 		20,000 66.05 US$1,321,000
2026-05-05 2026-05-05 PrS Proposed sale
3.0
SUNG LEE

Officer

Officer
23,906
66.05
US$1,578,991 		23,906 66.05 US$1,578,991
2026-05-05 2026-05-05 S Sale
2.9
WIERENGA WENDELL
Non-Executive Director
4,032 -11.0%
75.00
US$302,400 		4,032 -11.0% 75.00 US$302,400
2026-05-05 2026-05-05 S Sale
3.0
Lee Sung

EVP, Chief Financial Officer

Officer
23,906 -27.4%
76.87
US$1,837,654 		23,906 -27.4% 76.87 US$1,837,654
2026-05-05 2026-05-05 S Sale
3.7
HENDERSON JOHN T
Non-Executive Director
20,000 -21.0%
75.97
US$1,519,400 		20,000 -21.0% 75.97 US$1,519,400
2026-05-05 2026-05-05 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
11,333 -16.2%
77.25
US$875,474 		11,333 -16.2% 77.25 US$875,474
2026-05-04 2026-05-01 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
15,857 -21.3%
65.00
US$1,030,705 		15,857 -21.3% 65.00 US$1,030,705
2026-04-30 2026-04-30 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
15,000 -20.4%
63.26
US$948,900 		15,000 -20.4% 63.26 US$948,900
2026-04-29 2026-04-29 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
7,500 -1.8%
59.62
US$447,150 		7,500 -1.8% 59.62 US$447,150
2026-04-21 2026-04-21 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
3,500 -2.2%
65.69
US$229,915 		3,500 -2.2% 65.69 US$229,915
2026-04-15 2026-04-15 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
7,449 -11.3%
66.02
US$491,783 		7,449 -11.3% 66.02 US$491,783
2026-04-15 2026-04-15 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
7,500 -1.8%
65.38
US$490,350 		7,500 -1.8% 65.38 US$490,350
2026-04-15 2026-04-15 PrS Proposed sale
2.9
ANDREW CALLOS

Officer

Officer
79,639
66.35
US$5,284,048 		79,639 66.35 US$5,284,048
2026-04-08 2026-04-07 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
1,000 -0.6%
64.75
US$64,750 		1,000 -0.6% 64.75 US$64,750
2026-04-08 2026-04-07 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
3,500 -2.2%
65.21
US$228,235 		3,500 -2.2% 65.21 US$228,235
2026-04-07 2026-04-07 PrS Proposed sale
3.6
FADY MALIK

Officer

Officer
22,000
64.94
US$1,428,680 		22,000 64.94 US$1,428,680
2026-04-01 2026-04-01 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
7,500 -1.7%
66.63
US$499,725 		7,500 -1.7% 66.63 US$499,725
2026-04-01 2026-04-01 PrS Proposed sale
2.7
ROBERT BLUM

Director; Officer

Executive Director
45,000
65.91
US$2,965,950 		45,000 65.91 US$2,965,950
2026-03-31 2026-03-31 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
3,639 -5.2%
65.00
US$236,535 		3,639 -5.2% 65.00 US$236,535
2026-03-31 2026-03-31 PrS Proposed sale
2.9
ANDREW CALLOS

Officer

Officer
3,639
62.97
US$229,148 		3,639 62.97 US$229,148
2026-03-18 2026-03-18 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
1,930 -2.4%
62.07
US$119,795 		1,930 -2.4% 62.07 US$119,795
2026-03-18 2026-03-18 PrS Proposed sale
2.9
ANDREW CALLOS

Officer

Officer
1,930
62.13
US$119,911 		1,930 62.13 US$119,911
2026-03-18 2026-03-17 S Sale
3.0
Lee Sung

EVP, Chief Financial Officer

Officer
4,935 -5.4%
62.15
US$306,710 		4,935 -5.4% 62.15 US$306,710
2026-03-18 2026-03-17 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
2,916 -3.9%
62.15
US$181,229 		2,916 -3.9% 62.15 US$181,229
2026-03-18 2026-03-17 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
5,626 -7.0%
62.15
US$349,656 		5,626 -7.0% 62.15 US$349,656
2026-03-18 2026-03-17 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
4,397 -2.8%
62.15
US$273,274 		4,397 -2.8% 62.15 US$273,274
2026-03-18 2026-03-17 S Sale
3.6
Malik Fady Ibraham

EVP Research & Development

Officer
7,636 -4.6%
62.15
US$474,577 		7,636 -4.6% 62.15 US$474,577
2026-03-18 2026-03-17 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
23,928 -5.3%
62.15
US$1,487,125 		23,928 -5.3% 62.15 US$1,487,125
2026-03-18 2026-03-17 S Sale
2.7
Blum Robert I

President & CEO

Executive Director
12,673 -2.7%
62.15
US$787,627 		12,673 -2.7% 62.15 US$787,627
2026-03-16 2026-03-16 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
1,709 -3.6%
61.03
US$104,300 		1,709 -3.6% 61.03 US$104,300
2026-03-16 2026-03-16 PrS Proposed sale
2.9
ANDREW CALLOS

Officer

Officer
1,709
60.06
US$102,643 		1,709 60.06 US$102,643
2026-03-10 2026-03-09 S Sale
2.9
Callos Andrew

EVP, Chief Commercial Officer

Officer
2,582 -5.1%
60.72
US$156,779 		2,582 -5.1% 60.72 US$156,779
Explore more

More insider trading research around Cytokinetics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America